At what enterprise value was Rovensa acquired in 2016?

During the acquisition of Rovensa by BRIDGEPOINT in 2016, the transaction's Enterprise Value is estimated to be in the range of 300M - 700M EUR.

What was the EV/EBITDA of Rovensa when it was acquired by BRIDGEPOINT?

The estimated EV/EBITDA multiple for Rovensa is in the range of 10x - 18x.

When was Rovensa acquired by BRIDGEPOINT?

Rovensa was acquired by BRIDGEPOINT in 2016.

What was the revenue of Rovensa at the time of the deal?

The revenue of Rovensa at the time of the deal is estimated to be in the range of 100M - 200M EUR.

What was the EBITDA of Rovensa during the acquisition?

Rovensa's EBITDA is estimated to be in the range of 25M - 50M EUR.

How is the data for the Rovensa acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the Rovensa deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.agriinvestor.com/bridgepoint-to-acquire-sapec-agro-business/

← DATABASE

Home Database Industry & ManufacturingRovensa

12/2016

Rovensa acquired by BRIDGEPOINT

PORTUGAL Chemicals & Materials / Specialty Chemicals EV 300M - 700M EUR

Context

The European private equity firm Bridgepoint finalizes the acquisition of the Portuguese agrochemical specialist Sapec Agro (now Rovensa) in a primary buyout transaction valuing the target at an enterprise value of . Executed in late 2016 and officially closed during the 2017 fiscal year, this definitive ownership transfer incorporates the Iberian crop protection leader into the acquirer's diversified industrial portfolio. The strategic rationale underpinning this institutional capital deployment centers on aggressively scaling the target's international footprint and consolidating its prominent market position within the rapidly expanding biological agricultural solutions sector. By injecting fresh financial resources and institutional governance frameworks, the incoming majority shareholder aims to accelerate the company's research-led pipeline and execute a rigorous external growth strategy to penetrate new geographies. The post-acquisition roadmap specifically allocates significant capital reserves to fund strategic add-on acquisitions, enabling the target to internalize complementary bio-nutrition technologies and expand its European manufacturing capacity. This targeted buy-and-build consolidation framework is designed to actively transition the company from a regional market leader into a globally diversified biosolutions platform, perfectly positioned to deliver bespoke agricultural inputs to a highly regulated and environmentally conscious international farming base. The transaction execution mobilized specialized financial and legal advisory syndicates to conduct comprehensive commercial and operational due diligence prior to final signature. Following the successful capital restructuring, the target entity was comprehensively rebranded to better reflect its renewed global ambitions and specialized focus on sustainable agronomic paradigms under the exclusive strategic backing of its new private equity owner. This structural shift effectively provides the executive management team with the autonomous operational agility and robust financial backing required to navigate the increasingly complex regulatory landscapes governing international agrochemical distribution and secure long-term global market share.

-> Deep-dive in Industry & Manufacturing market trends

Target

Rovensa operates as a specialized provider of agricultural biosolutions and biocontrol technologies headquartered in Portugal. Founded in 1926, the independent industrial company engineers and formulates sustainable crop nutrition and protection products explicitly designed to enhance agricultural yields while minimizing ecological impacts. The operational architecture is rigidly organized into three distinct manufacturing and research divisions: BioNutrition, which supplies essential nutrients for healthy crop development; Crop Protection, which focuses on eliminating or preventing biological threats; and BioControl, which utilizes biological inputs such as plant extracts and micro-organisms. By deploying these specialized biorational and biostimulant portfolios, the enterprise assists farmers in addressing global food security challenges, combating agriculture's wider contribution to climate change, and cultivating healthy food. The organization maintains a vast international distribution footprint, ensuring its proprietary agricultural solutions are actively sold across more than 70 countries worldwide. Relying on robust, centralized research and development capabilities, the firm continuously innovates within high-growth market niches, providing critical technologies that mitigate natural resource degradation and biodiversity loss.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2016

2015

Other operations with Rovensa

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
07/2020	PARTNERS GROUP	Rovensa	PORTUGAL	Specialty Chemicals

REFERENCES

Valuation range: EV 300M - 700M EUR

Revenue range: 100M - 200M EUR

EBITDA range: 25M - 50M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Rovensa by BRIDGEPOINT are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: rovensa

Acquirer: bridgepoint